CD46 | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Trial results

31 July 2024

FibroGen finally walks away from pamrevlumab

Interviews

24 April 2024

FibroGen throws down the prostate cancer gauntlet

Amid doubts about early data with FG-3246, the group is scathing about its rivals.

Subscribe to CD46